significant interaction between gemfibrozil (Lopid, etc) and repaglinide (Prandin) has just been identified

June 2003

A significant interaction between gemfibrozil (Lopid, etc) and repaglinide (Prandin) has just been identified.

These drugs are likely to be used together. Many diabetes patients get gemfibrozil to lower triglycerides and increase HDL.

But the interaction is probably not in your computer yet.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

any blood pressure over 115/75 increases the risk of death from heart disease and stroke
Diabetes significant interaction between gemfibrozil (Lopid, etc) and repaglinide (Prandin) has just been identified
Obesity & Weight Loss people are asking about the best ways to lose weight
Anticoagulants aspirin instead of warfarin to prevent stroke in some atrial fibrillation patients
Hormone Therapy new lower strength of Premarin and Prempro
Hormone Therapy Prempro INCREASES the risk of urinary incontinence in postmenopausal women
Cardiology using high-dose folate, B6, and B12 supplements after angioplasty
Cardiology Should sublingual nitroglycerin (SL NTG) be discarded 6 months after being opened?
Bell's Palsy how to treat Bell's palsy
Dermatology new OTC wart remover, called Wartner
Women's Health ONE dose of Plan B is now being used for emergency contraception
Hematology & Oncology whether garlic prevents cancer
Hematology & Oncology New cancer drugs are making headlines, Iressa, Velcade, Avastin
Do powered toothbrushes work better than manual toothbrushes?
"Asheville Project" is helping prove the value of pharmacists' SERVICES